Suchergebnisse - "Hu, Yi"

PubPharm (56)

1

Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer

enthalten in: Current problems in cancer | 2021

von Li, T. | Huang, H. | Hu, Y. | +8

2

Response to first-line treatment predicts progression-free survival benefit of small-cell lung cancer patients treated with anlotinib

enthalten in: Cancer medicine | 2021

von Qin, B. | Xin, L. | Hou, Q. | +6

3

Two Different Inoculation Methods Unveiled the Relative Independence of DON Accumulation in Wheat Kernels from Disease Severity on Spike after Infection by Fusarium Head Blight

enthalten in: Toxins | 2021

von Wang, R. | Hua, C. | Hu, Y. | +3

4

Efficacy of rapid on-site cytological evaluation (ROSE) by a pulmonologist in determining specimen adequacy and diagnostic accuracy in interventional diagnosis of lung lesions

enthalten in: The Journal of international medical research | 2021

von Yuan, M. | Wang, Y. | Yin, W. | +3

5

Asterid Phylogenomics/Phylotranscriptomics Uncover Morphological Evolutionary Histories and Support Phylogenetic Placement for Numerous Whole-Genome Duplications

enthalten in: Molecular biology and evolution | 2020

von Zhang, C. | Zhang, T. | Luebert, F. | +8

6

Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC

enthalten in: Scientific reports | 2020

von Cui, P. | Li, R. | Huang, Z. | +4

7

A Comparative Study of Patients' Subjective Feelings Toward Total Hip Arthroplasty with Patient-Specific Instruments and Traditional Total Hip Arthroplasty

enthalten in: Orthopaedic surgery | 2020

von Xing, Q. | Zhong, D. | Pan, Y. | +5

8

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

enthalten in: The New England journal of medicine | 2020

von Ramalingam, S. | Vansteenkiste, J. | Planchard, D. | +122

CommentIn: Lancet Oncol. 2020 Jan;21(1):e15. - PMID 31787537

9

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042) : a randomised, open-label, controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Mok, T. | Wu, Y. | Kudaba, I. | +113

CommentIn: Nat Rev Clin Oncol. 2019 Jul;16(7):403. - PMID 30992570

10

Efficient Degradation of High-Molecular-Weight Hyaluronic Acid by a Combination of Ultrasound, Hydrogen Peroxide, and Copper Ion

enthalten in: Molecules (Basel, Switzerland) | 2019

von Chen, H. | Qin, J. | Hu, Y.

1
2
3
4
5
6
Nächster »
[6]